Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 1996

Wellbutrin Sr(Bupropion Hcl)GSK plc logoGSK

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by GSK plc

$5.2M

Medicare cost, 2024

Medicare drug plans spent $5.2 million on Wellbutrin Sr (bupropion hcl) in 2024, for 6,091 prescriptions and refills filled by 1,307 patients. California accounts for the most spending ($848,318, 16% of the total). It is made by GSK plc (GSK).

Medicare cost, 2024

$5.2M

-9.5% from 2023

Prescriptions

6,091

$852.99 per claim

Patients

1,307

1,530 prescribers

Total spending, 2024

$5.2M

$3,975.16 per patient

Questions and answers

How much does Medicare spend on Wellbutrin Sr?

Medicare prescription drug plans paid $5.2M for Wellbutrin Sr in 2024, for 6,091 prescriptions and refills to 1,307 patients (down 9.5% from 2023). The average cost per claim was $852.99.

Which state spends the most on Wellbutrin Sr?

California had the highest Medicare cost for Wellbutrin Sr in 2024: $848K for 830 claims, followed by New York ($484K).

Who prescribes Wellbutrin Sr the most?

Franklin D Russek, psychiatry in New York, NY, had the highest Medicare cost for Wellbutrin Sr in 2024: 13 claims costing $21K.

Who makes Wellbutrin Sr?

Wellbutrin Sr is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Wellbutrin Sr was $5.2M in 2024, after a high of $6.2M in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Wellbutrin Sr, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Franklin D Russek New York, NYPsychiatry13Under 11$21K
John D Fenley Johnson City, TNPsychiatry & Neurology12Under 11$20K
John A Grimaldi Jr. Boston, MAPsychiatry18Under 11$20K
Alexandra Potock Sewickley, PAInternal Medicine11Under 11$14K
Thomas R Lux Houston, TXInternal Medicine11Under 11$12K
Rashelle Tomlinson Stockbridge, GAPsychiatry13Under 11$12K
Robert J Sevenich Saint Paul, MNPsychiatry11Under 11$12K
Ashley McCorkle Buffalo, NYInternal Medicine13Under 11$11K
Pilar Lachhwani Cleveland, OHPsychiatry11Under 11$11K
Thomas D Long Jr. Roxboro, NCInternal Medicine13Under 11$11K
Jeffrey B Warren Loveland, COPsychiatry13Under 11$11K
Jane Simon New York, NYPsychiatry & Neurology12Under 11$11K
James P Reed Sierra Vista, AZPsychiatry16Under 11$11K
Stephen D Henry Pasadena, CAInternal Medicine12Under 11$10K
Aloysius L Davis Longmeadow, MAPsychiatry12Under 11$10K
Jessica S Lucero Las Vegas, NVNurse Practitioner12Under 11$10K
Samuel G Welch Mt Sterling, KYPsychiatry12Under 11$10K
Marjorie A Harelick Arlington, VAPsychiatry12Under 11$10K
Mary E Daly Saginaw, MINurse Practitioner12Under 11$10K
Donald D Scalea Marlton, NJPsychiatry & Neurology12Under 11$10K
Emily E Bucy Boulder, COPsychiatry12Under 11$10K
Kathy D Mayo Greenville, NCPsychiatry & Neurology12Under 11$10K
Birgit Amann Troy, MIPsychiatry13Under 11$10K
Anne E Marmorale Glen Oaks, NYNurse Practitioner12Under 11$10K
Suzanne M Kontak Ronkonkoma, NYNurse Practitioner15Under 11$9,991

Prescriber data by year

YearPrescribersClaimsPatientsCost
20221,7116,9381,466$5.7M
20231,5956,5881,370$5.7M
20241,5306,0911,307$5.2M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
GlaxosmithklineGSK logoGSK6,091$5.2M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
3
RxNorm concept IDs
993503, 993511, 993518, 993528, 993536
Application numbers
NDA020358

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube